Related content

Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder

By Anderson Rodney   MacDiarmid Scott   Kell Sherron   Barada James   Serels Scott   Goldberg Roger  

International Urogynecology Journal, Vol. 17, Iss. 5, 2006-10 ,pp. : 502-511

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Dry Mouth in Women Treated with Extended-Release Formulations of Oxybutynin or Tolterodine for Overactive Bladder

By Armstrong Robert   Luber Karl   Peters Kenneth  

International Urology and Nephrology, Vol. 37, Iss. 2, 2005-06 ,pp. : 247-252

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial

By Homma Y.  

World Journal of Urology, Vol. 22, Iss. 4, 2004-08 ,pp. : 251-256

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Safety, Tolerability and Efficacy of Extended-Release Tolterodine in the Treatment of Overactive Bladder

By Kreder K.   Mayne C.   Jonas U.  

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 588-595

Elsevier

Access to resources Recommend Favorite

A prospective observational study of the effects of treatment with extended-release tolterodine on health-related quality of life of patients suffering overactive bladder syndrome in Sweden

By Peeker Ralph   Samsioe Gööran   Kowalski Jan   Andersson Ann-Sofie   Bergqvist Agneta  

Scandinavian Journal of Urology and Nephrology, Vol. 44, Iss. 3, 2010-04 ,pp. : 138-146

Informa Healthcare

Access to resources Recommend Favorite